TGF-β1 signaling and Krüppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization

Blood

Volumn 118, Issue 24, 2011, Pages 6450-6460

  Wara, Akm Khyrul ^a   Foo, ShiYin ^b   Croce, Kevin ^a   Sun, Xinghui ^a   Icli, Basak ^a   Tesmenitsky, Yevgenia ^a   Esen, Fehim ^a   Lee, Jung Soo ^a   Subramaniam, Malayannan ^c   Spelsberg, Thomas C ^c   Lev, Eli I ^d   Leshem Lev, Dorit ^d   Pande, Reena L ^a   Creager, Mark A ^a   Rosenzweig, Anthony ^b   Feinberg, Mark W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 10; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL FUNCTION; COLONY FORMING UNIT GM; CONTROLLED STUDY; LEG ISCHEMIA; MALE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 83455219317     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-363713     Document Type: Article

References (45)

1. Kawamoto A, Losordo DW. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med. 2008;18(1):33-37.
2. Burt RK, Loh Y, Pearce W, et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases [see comment]. JAMA. 2008;299(8):925-936. (Pubitemid 351397068)
3. Fadini GP, Sartore S, Albiero M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol. 2006;26(9):2140-2146. (Pubitemid 44253800)
4. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1-7.
5. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk [see comment]. [reprint in Can J Cardiol. 2004;20(suppl B):44B-48B]. N Engl J Med. 2003;348(7):593-600. (Pubitemid 36204953)
6. Tongers J, Roncalli JG, Losordo DW. Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age [see comment]. Circulation. 2008;118(1):9-16.
7. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial [see comment]. Lancet. 2002;360(9331):427-435.
8. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9(6):702-712. (Pubitemid 36749219)
9. Devanesan AJ, Laughlan KA, Girn HR, Homer-Vanniasinkam S. Endothelial progenitor cells as a therapeutic option in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2009;38(4):475-481.
10. Wara AK, Croce K, Foo S-Y, et al. Bone marrow-derived CMPs and GMPs represent highly functional pro-angiogenic cells: implications for ischemic cardiovascular disease [published online ahead of print August 9, 2011]. Blood. doi: 10.1182/blood-2011-06-363457.
11. Feinberg MW, Jain MK. Role of transforming growth factor-beta1/Smads in regulating vascular inflammation and atherogenesis. Panminerva Medica. 2005;47(3):169-186. (Pubitemid 43387852)
12. Capron C, Lacout C, Lecluse Y, et al. A major role of TGF-beta1 in the homing capacities of murine hematopoietic stem cell/progenitors. Blood. 2010;116(8):1244-1253.
13. Franitza S, Kollet O, Brill A, et al. TGF-beta1 enhances SDF-1alpha-induced chemotaxis and homing of naive T cells by up-regulating CXCR4 expression and downstream cytoskeletal effector molecules. Eur J Immunol. 2002;32(1):193-202. (Pubitemid 34092837)
14. Sato K, Kawasaki H, Nagayama H, et al. TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J Immunol. 2000;164(5):2285-2295. (Pubitemid 30115454)
15. Basu S, Broxmeyer HE. Transforming growth factor-{beta}1 modulates responses of CD34+cord blood cells to stromal cell-derived factor-1/CXCL12. Blood. 2005;106(2):485-493. (Pubitemid 40981242)
16. Cao Z, Sun X, Icli B, Wara AK, Feinberg MW. Role of Kruppel-like factors in leukocyte development, function, and disease. Blood. 2010;116(22):4404-4414.
17. Feinberg MW, Lin Z, Fisch S, Jain MK. An emerging role for Kruppel-like factors in vascular biology. Trends Cardiovasc Med. 2004;14(6):241-246. (Pubitemid 39297022)
18. Subramaniam M, Gorny G, Johnsen SA, et al. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol Cell Biol. 2005;25(3):1191-1199. (Pubitemid 40165824)
19. Feinberg MW, Wara AK, Cao Z, et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 2007;26(18):4138-4148. (Pubitemid 47462091)
20. Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 1999;397(6721):710-713.
21. Ghosh AK, Yuan W, Mori Y, Chen S, Varga J. Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem. 2001;276(14):11041-11048. (Pubitemid 38089285)
22. Kommineni VK, Nagineni CN, William A, Detrick B, Hooks JJ. IFN-gamma acts as anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-Aand sVEGF-R1. Biochem Biophys Res Commun. 2008;374(3):479-484.
23. Subramaniam M, Hawse JR, Johnsen SA, Spelsberg TC. Role of TIEG1 in biological processes and disease states. J Cell Biochem. 2007;102(3):539-548. (Pubitemid 47557409)
24. Melero-Martin JM, Bischoff J. Chapter 13. An in vivo experimental model for postnatal vasculogenesis. Methods Enzymol. 2008;445:303-329.
25. Frontelo P, Manwani D, Galdass M, et al. Novel role for EKLF in megakaryocyte lineage commitment. Blood. 2007;110(12):3871-3880. (Pubitemid 350248442)
26. Alder JK, Georgantas RW III, Hildreth RL, et al. Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo. J Immunol. 2008;180(8):5645-5652.
27. Liao X, Sharma N, Kapadia F, et al. Kruppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011;121(7):2736-2749.
28. Boon RA, Urbich C, Fischer A, et al. Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells. Eur Heart J. 2011;32(3):371-377.
29. van Royen N, Hoefer I, Buschmann I, et al. Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEB J. 2002;16(3):432-434.
30. Mobius-Winkler S, Hollriegel R, Schuler G, Adams V. Endothelial progenitor cells: implications for cardiovascular disease. Cytometry A. 2009;75(1):25-37.
31. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008;28(9):1584-1595.
32. Bailey AS, Willenbring H, Jiang S, et al. Myeloid lineage progenitors give rise to vascular endothelium [see comment]. Proc Natl Acad Sci U S A. 2006;103(35):13156-13161. (Pubitemid 44338932)
33. Zhang J, Cao R, Zhang Y, Jia T, Cao Y, Wahlberg E. Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. FASEB J. 2009;23(1):153-163.
34. Lu H, Xu X, Zhang M, et al. Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proc Natl Acad Sci U S A. 2007;104(29):12140-12145. (Pubitemid 47185643)
35. Lindahl P, Johansson BR, Leveen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277(5323):242- 245. (Pubitemid 27446080)
36. Chavakis E, Dimmeler S. Homing of progenitor cells to ischemic tissues. Antioxid Redox Signal. 2011;15(4):967-980.
37. Fujiyama S, Amano K, Uehira K, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res. 2003;93(10):980-989. (Pubitemid 37433236)
38. Derynck R, Akhurst RJ. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol. 2007;9(9):1000-1004. (Pubitemid 47338137)
39. Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol. 2009;21(2):166-176.
40. Dvorin EL, Wylie-Sears J, Kaushal S, Martin DP, Bischoff J. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1. Tissue Eng. 2003;9(3):487-493. (Pubitemid 36736131)
41. Robinson AP, Foraker JE, Ylostalo J, Prockop DJ. Human stem/progenitor cells from bone marrow enhance glial differentiation of rat neural stem cells: a role for transforming growth factor beta and Notch signaling. Stem Cells Dev. 2011;20(2):289-300.
42. Poon E, Clermont F, Firpo MT, Akhurst RJ. TGFbeta inhibition of yolk-sac-like differentiation of human embryonic stem-cell-derived embryoid bodies illustrates differences between early mouse and human development. J Cell Sci. 2006;119(Pt 4):759-768.
43. Moonen JR, Krenning G, Brinker MG, Koerts JA, van Luyn MJ, Harmsen MC. Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc Res. 2010;86(3):506-515.
44. Imamura H, Ohta T, Tsunetoshi K, et al. Transdifferentiation of bone marrow-derived endothelial progenitor cells into the smooth muscle cell lineage mediated by tansforming growth factor-beta1. Atherosclerosis. 2010;211(1):114-121.
45. Mogi M, Walsh K, Iwai M, Horiuchi M. Akt-FOXO3a signaling affects human endothelial progenitor cell differentiation. Hypertens Res. 2008;31(1):153-159. (Pubitemid 351325627)